Betafact® (human coagulation factor IX)

Betafact is indicated for the treatment and prevention of bleeding episodes in patients with hemophilia B (congenital factor IX deficiency).

This product is only provided on a name patient basis after special permission from the local medical authority.

For further information on this product, please contact medical.info@sobi.com

Follow us by RSS

Follow us by e-mail

Our Locations